Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of medicine primarily in China. The company operates through Chemical and Biological Medicine, and Health Industry segments. It offers drugs for cardiac and premature ventricular beats, sinus bradycardia, chronic heart failure, integrated rhythm regulation, cold and respiratory, cardiovascular and cerebrovascular diseases, diabetes field, tumor medication, and others. The company sells its products through physical display and online. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.

Biotechnology

Ms. Wei  Wang

Deputy GM & Director of Administrative Center

Mr. Wei Dong  Xu

Executive Deputy Director of the Human Resources Center & Director

Ms. Rui  Wu

Secretary of the Board & Non-Independent Director

Mr. Xiang Jun  Wu

Chairman & GM

Mr. Chen Guang  Li

Chief Financial Officer & Director

Ms. Qiu Lian  Zhang

Deputy GM & Non-Independent Director

Mr. Xiaolin  Zhou

Deputy GM & Director of the Supply Center

Name	Market cap
Sorrento Therapeutics, Inc.	0M
Maravai LifeSciences Holdings, Inc.	0M
Comera Life Sciences Holdings, Inc.	0M
Gubra A/S	0M
CytoTools AG	0M
Hofseth BioCare ASA	0M
Shanghai Haohai Biological Technology Co., Ltd.	0M
Purple Biotech Ltd.	0M

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Shijiazhuang Yiling Pharmaceutical Co., Ltd. Competitors List

Main competitors